Morgan Brown

Track

Insider profile

Currently holds a position at Lipocine Inc

Positions

Position Company Period
Chief Financial Officer, Executive Vice President Lipocine Inc Sept. 15, 2013 -
Chief Financial Officer, Executive Vice President Innovus Pharmaceuticals Inc May 28, 2013 - Sept. 22, 2013
Morgan Brown's trades of Lipocine Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Lipocine Inc (LPCN)
Transaction date
Planned sale
Price
186.78
Quantity 42,586 +39.1%
Value US$496,599
US Lipocine Inc (LPCN)
Transaction date
Planned sale
Price
372.76
Quantity 20,722 -41.7%
Value US$4,791,713
US Lipocine Inc (LPCN)
Transaction date
Planned sale
Price
33.95
Quantity 47,994 +4.2%
Value US$2,011,303
US Lipocine Inc (LPCN)
Transaction date
Planned sale
Price
3.47
Quantity 2,813 -10.7%
Value US$9,773
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2020-12-17 2020-12-16
US Lipocine Inc (LPCN)
PlS Planned sale
42,586 +39.1%
186.78
US$496,599 		42,586 +39.1% 186.78 US$496,599
2020-12-08 2020-12-04
US Lipocine Inc (LPCN)
PlS Planned sale
20,722 -41.7%
372.76
US$4,791,713 		20,722 -41.7% 372.76 US$4,791,713
2019-12-06 2019-12-04
US Lipocine Inc (LPCN)
PlS Planned sale
47,994 +4.2%
33.95
US$2,011,303 		47,994 +4.2% 33.95 US$2,011,303
2018-01-02 2017-12-29
US Lipocine Inc (LPCN)
PlS Planned sale
2,813 -10.7%
3.47
US$9,773 		2,813 -10.7% 3.47 US$9,773